[go: up one dir, main page]

GB202114528D0 - Lentiviral vectors - Google Patents

Lentiviral vectors

Info

Publication number
GB202114528D0
GB202114528D0 GBGB2114528.9A GB202114528A GB202114528D0 GB 202114528 D0 GB202114528 D0 GB 202114528D0 GB 202114528 A GB202114528 A GB 202114528A GB 202114528 D0 GB202114528 D0 GB 202114528D0
Authority
GB
United Kingdom
Prior art keywords
lentiviral vectors
lentiviral
vectors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2114528.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxford Biomedica UK Ltd
Original Assignee
Oxford Biomedica UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxford Biomedica UK Ltd filed Critical Oxford Biomedica UK Ltd
Priority to GBGB2114528.9A priority Critical patent/GB202114528D0/en
Publication of GB202114528D0 publication Critical patent/GB202114528D0/en
Priority to PCT/GB2022/052582 priority patent/WO2023062363A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/16043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/42—Vector systems having a special element relevant for transcription being an intron or intervening sequence for splicing and/or stability of RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/44—Vectors comprising a special translation-regulating system being a specific part of the splice mechanism, e.g. donor, acceptor

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
GBGB2114528.9A 2021-10-12 2021-10-12 Lentiviral vectors Ceased GB202114528D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB2114528.9A GB202114528D0 (en) 2021-10-12 2021-10-12 Lentiviral vectors
PCT/GB2022/052582 WO2023062363A1 (en) 2021-10-12 2022-10-12 Lentiviral vectors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2114528.9A GB202114528D0 (en) 2021-10-12 2021-10-12 Lentiviral vectors

Publications (1)

Publication Number Publication Date
GB202114528D0 true GB202114528D0 (en) 2021-11-24

Family

ID=78595110

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2114528.9A Ceased GB202114528D0 (en) 2021-10-12 2021-10-12 Lentiviral vectors

Country Status (2)

Country Link
GB (1) GB202114528D0 (en)
WO (1) WO2023062363A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB202401004D0 (en) * 2024-01-25 2024-03-13 Oxford Genetics Ltd Retroviral vectors
CN120041454B (en) * 2025-04-22 2025-07-29 上海朗昇生物科技有限公司 Mutant promoter and application thereof

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5512421A (en) 1991-02-19 1996-04-30 The Regents Of The University Of California Generation, concentration and efficient transfer of VSV-G pseudotyped retroviral vectors
US5723315A (en) 1996-08-23 1998-03-03 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
US6100071A (en) 1996-05-07 2000-08-08 Genentech, Inc. Receptors as novel inhibitors of vascular endothelial growth factor activity and processes for their production
JP2000517297A (en) 1996-08-07 2000-12-26 ダーウィン・ディスカバリー・リミテッド Hydroxamic acid derivatives and carboxylic acid derivatives having MMP and TNF inhibitory activities
US6126939A (en) 1996-09-03 2000-10-03 Yeda Research And Development Co. Ltd. Anti-inflammatory dipeptide and pharmaceutical composition thereof
DE69703974T2 (en) 1996-10-17 2001-07-19 Oxford Biomedica (Uk) Ltd., Oxford RETROVIRAL VECTORS
US6924123B2 (en) 1996-10-29 2005-08-02 Oxford Biomedica (Uk) Limited Lentiviral LTR-deleted vector
US6136597A (en) 1997-09-18 2000-10-24 The Salk Institute For Biological Studies RNA export element
AU760287B2 (en) 1997-12-22 2003-05-08 Oxford Biomedica (Uk) Limited Equine infectious anaemia virus (EIAV) based
GB9803351D0 (en) 1998-02-17 1998-04-15 Oxford Biomedica Ltd Anti-viral vectors
GB9904905D0 (en) 1999-03-03 1999-04-28 Oxford Biomedica Ltd Cells
GB0009760D0 (en) 2000-04-19 2000-06-07 Oxford Biomedica Ltd Method
US7419829B2 (en) 2000-10-06 2008-09-02 Oxford Biomedica (Uk) Limited Vector system
WO2003064665A2 (en) 2002-02-01 2003-08-07 Oxford Biomedica (Uk) Limited Viral vector
EP1534847B1 (en) 2002-09-03 2015-10-28 Oxford Biomedica (UK) Limited Retroviral vector and stable packaging cell lines
FR2872170B1 (en) 2004-06-25 2006-11-10 Centre Nat Rech Scient Cnrse NON-INTERACTIVE AND NON-REPLICATIVE LENTIVIRUS, PREPARATION AND USES
GB0526211D0 (en) 2005-12-22 2006-02-01 Oxford Biomedica Ltd Viral vectors
GB0526210D0 (en) 2005-12-22 2006-02-01 Oxford Biomedica Ltd Vectors
JP5615271B2 (en) 2008-06-18 2014-10-29 オックスフォード バイオメディカ（ユーケー）リミテッド Virus purification method
GB201322798D0 (en) 2013-12-20 2014-02-05 Oxford Biomedica Ltd Production system
FI3633040T3 (en) 2017-12-22 2023-08-03 Oxford Biomedica Ltd RETROVIRUS VECTOR
JP7787064B2 (en) 2019-07-23 2025-12-16 オックスフォード バイオメディカ（ユーケー）リミテッド Enhanced lentiviral vector production
CN114667161A (en) 2019-11-12 2022-06-24 牛津生物医学（英国）有限公司 Production system
EP4103723A1 (en) 2020-02-13 2022-12-21 Oxford BioMedica (UK) Limited Production of lentiviral vectors
EP4118217A1 (en) 2020-03-13 2023-01-18 Oxford BioMedica (UK) Limited Lentiviral vectors

Also Published As

Publication number Publication date
WO2023062363A1 (en) 2023-04-20

Similar Documents

Publication Publication Date Title
GB201800903D0 (en) Vectors
SG11202001367QA (en) Retroviral vectors
IL291632B1 (en) Lentiviral vector formulations
GB202010009D0 (en) Vector
GB2590774B (en) Vector
GB202019108D0 (en) Vector
PT4041626T (en) Watercraft
GB202114528D0 (en) Lentiviral vectors
GB202114532D0 (en) Lentiviral Vectors
GB202205606D0 (en) Lentiviral vector
SG11202102012SA (en) Improved lentiviral vector
GB201913974D0 (en) Vector
GB202114529D0 (en) Lentiviral vectors
IL316172A (en) Lentiviral vector
IL308705A (en) Lentiviral vector
GB201906283D0 (en) Vector
GB202114530D0 (en) Retroviral vectors
GB202003710D0 (en) Lentiviral vectors
GB202003709D0 (en) Lentiviral vectors
GB202003711D0 (en) Lentiviral vectors
GB202214990D0 (en) Lentiviral vector
GB202214973D0 (en) Lentiviral vector
GB202205608D0 (en) Lentiviral vector
GB202205615D0 (en) Lentiviral vector
IL304808A (en) Retroviral vectors

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)